Skip to main content
Not Found

F23-701 Exploring Cannabis Science and Therapeutics and Social Work Practice

Total Credits: 6 including 6 Category I CE

700 Professional Growth & Development |  800 Online
Paulette S. Smith, LCSW-C
Course Levels:
3 hours



This training offers participants a broad look at medical cannabis and social work practice, including the history and current trends. Participants will be introduced to the ways cannabis and its constituents work in the human body and research probing how it can be used as a treatment method for physical and mental health conditions. Participants will examine the history of cannabis prohibition and discuss how federal regulations have overwhelmingly negatively affected Black and Brown communities. Participants will review social work principles and analyze their place in the cannabis industry. Additionally, principles of safe practices that support client safety are explored.  


Paulette S. Smith, LCSW-C Related seminars and products

Paulette Simone Smith, MS, LCSW-C is the Founder and CEO of Paulette Simone & Associate, LLC (PS&A), a Baltimore, Maryland-based mental health counseling practice, and Canna Heals, an organization with a mission to build knowledge and close gaps between cannabis consumers and the dispensary. Originally from Harlem, New York, Paulette earned an MS in Medical Cannabis Science and Therapeutics from the University of Maryland School of Pharmacy. She received her MSW from Morgan State University School of Social Work, concentrating in School Social Work. Paulette earned her bachelor's degree from Bowie State University, majoring in communications and broadcast journalism. Paulette is a board-certified social work supervisor in the State of Maryland.   

With over a decade of experience in adolescent and family wellness. Paulette brings together a combination of holistic practice and trauma-informed care to the field of health and wellness. She has built a reputation for centering client needs with precision problem-solving during her career.  

Additionally, her work in the creative arts as owner and operator of How I See It Productions also reflects her capacity for capturing and cultivating peaceful environments promoting wellness and a healthy family environment. Ms. Smith is sought after for guidance on and support in holistic practices, including but not limited to presenting at conferences and meetings exploring health, wellness, and entrepreneurship—particularly among minority groups.  

Agenda & Learning Objectives


8:50 – 9:00 Log On/Registration  

9:00 – 10:45  

  • Cannabis the plant with many parts  

  • Consumption methods  

  • Breakout room discussion 

  • Cannabis prohibition timeline  

10:45 – 11 AM Break 

11:00 – 12:00  

The war on drugs 

Synthetic cannabinoids 

Drug testing 

Impending cannabis laws and regulations 

Large group discussion  

12 – 1 Lunch 

1:00 – 2:15  

  • How does cannabis work in the body 

  • What does the research say 

2:15 PM – 2:30 PM Break 

2:30 – 4:30  

  • Medical cannabis and mental health 

  • Breakout room activity 

  • Cannabis use disorder 

  • Cannabis toxicity 

  • Cannabis and harm reduction 

  • Social work core values and medical cannabis therapeutics 

  • Cannabis science and therapeutics and social work practice  

  • Large group discussion 

4:30 Questions and adjournment 



Upon the completion of this workshop, participants will be able to:

  • Identify ways in which social injustices caused by the history of cannabis prohibition and the ongoing War on Drugs have negatively affected Black and Brown communities.  

  • Learn how cannabis and its constituents work in the human body.  

  • Examine current research findings on medical cannabis and treatment strategies for selected physical and mental health conditions including: chronic pain, psychosis, depression, anxiety, PTSD, and bipolar disorder.  

  • Learn ways in which clinicians can dialogue with their clients about cannabis use.  

Bibliography & References


American Psychological Association. APA Dictionary of Psychology Retrieved from  

Aizpurua-Olaizola O, Elezgarai I, Rico-Barrio I, Zarandona I, Etxebarria N, Usobiaga A (January 2017). "Targeting the endocannabinoid system: future therapeutic strategies". Drug Discovery Today. 22 (1): 105–110. 

American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Association, 2013. 

Arevalo-Martin A, Garcia-Ovejero D, Gomez O, et al. CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies. Br J Pharmacol. 2008;153:216–225.  

Backes, M Cannabis Pharmacy The Practical Guide to Medical Marijuana December 2017 p. 239-240 

Bailey, Rahn. January 22, 2014. Cannabinoids 101: What Makes Cannabis Medicine? Leafly. Retrieved from 

Bergamaschi MM, Queiroz RH, Zuardi AW, Crippa JA (2011) Safety and side effects of cannabidiol, a Cannabis sativa constitu- ent. Curr Drug Saf 6(4):237–49  

Botsford, S, Yang, S, George, T. Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential The American Journal on Addictions, 29: 9–26, 2020 © 2019 American Academy of Addiction Psychiatry ISSN: 1055-0496 print / 1521-0391 online DOI: 10.1111/ajad.12963  

Bjorge, Philip. March 4, 2020. Cannabis tinctures 101: How to make, consume, and dose them. Leafly. 

Brenan, Megan. November 9, 2020 Support for Legal Marijuana Inches Up to New High of 68%. Gallup. Retrieved from  

Bridgeman MB, Abazia DT. Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting. P T. 2017;42(3):180-188 

Cannabis Overview. National Conference of State Legislatures. October 17, 2019. 

Carter, Alan, Raypole, Crystal. May 17, 2019 A Simple Guide to the Endocannabinoid System. Retrieved from 

Centonze D, Bari M, Rossi S, et al. The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. Brain. 2007;130:2543–2553.  

Crippa, J.A., Derenusson, G.N., Chagas, M.H. et al. Pharmacological interventions in the treatment of the acute effects of cannabis: a systematic review of literature. Harm Reduct J 9, 7 (2012). 

Cuijpers P, van Straten A, Warmerdam L, Andersson G. Psychotherapy versus the combination of psychotherapy and pharmacotherapy in the treatment of depression: a meta-analysis. Depress Anxiety. 2009;26(3):279-88. 

Curr Drug Abuse Rev. 2011 Dec; 4(4): 241–249.DEA United Sates Drug Enforcement  

Administration. Drug Scheduling. Retrieved from  

De Pietro, MaryAnn Aremu, Femi February 26, 2021 What to know about endocannabinoids and the endocannabinoid system. Medical News Today. Retrieved from 

Donvito G, Nass SR, Wilkerson JL, Curry ZA, Schurman LD, Kinsey SG, Lichtman AH (January 2018). The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain. Neuropsychopharmacology. 43 (1): 52–79. 

Elms L, Shannon S, Hughes S, Lewis N. Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series. J Altern Complement Med. 2019;25(4):392-397. doi:10.1089/acm.2018.0437 

Endocannabinoid System - an overview. ScienceDirect Topics. Retrieved from 

Fakhoury, M. Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia. Mol Neurobiol 54, 768–778 (2017). 

Freitas HR, Isaac AR, Silva TM, Diniz GO, Dos Santos Dabdab Y, Bockmann EC, et al. (September 2019). Cannabinoids Induce Cell Death and Promote P2X7 Receptor Signaling in Retinal Glial Progenitors in Culture. Molecular Neurobiology. 56 (9): 6472–6486. 

Freitas HR, Reis RA, Ventura AL, França GR (December 2019). Interaction between cannabinoid and nucleotide systems as a new mechanism of signaling in retinal cell death. Neural Regeneration Research. 14 (12): 2093–2094. 

Fride E (October 2004). "The endocannabinoid-CB(1) receptor system in pre- and postnatal life". European Journal of Pharmacology. SPECIAL CELEBRATORY VOLUME 500 Dedicated to Professor David de Wied Honorary and Founding Editor. 500 (1–3): 289–97. 

Grande I, Vieta E. Pharmacotherapy of acute mania: monotherapy or combination therapy with mood stabilizers and antipsychotics? CNS Drugs. 2015 Mar;29(3):221-7. 

Hallum, Mark. March 10, 2011 American Civil Liberties Union, A Tale of Two Countries: Racially Targeted Arrests in the Era of Marijuana Reform, 2020 ACLU. Retrieved from 

Hallum, Mark. March 10, 2021 People of color made up 94% of marijuana arrests by NYPD in 2020, data and Legal Aid says. AMNY. Retrieved from  

Hartman, Michael. July 6, 2021 Twenty-seven states and the District of Columbia have decriminalized small amounts of marijuana. 

Hill, Bryan. October 17, 2018 Legalized Marijuana: Canada Comes Round to the Wisdom of Ages Ancient Origins. Retrieved from  

Hindocha, C., Cousijn, J., Rall, M., & Bloomfield, M. A. P. (2020). The Effectiveness of Cannabinoids in the Treatment of Posttraumatic Stress Disorder (PTSD): A Systematic Review. Journal of dual diagnosis, 16(1), 120-139.  

How to Find the Right Strain For You. February 24, 2021. Retrieved from,variation)%20is%20becoming%20increasingly%20popular. 

Hudak, John. Marijuana A Short History Second Edition, Washington, DC 2020  

Hudak, John. December 14, 2012 The Farm Bill, hemp legalization and the status of CBD: An explainer. Brookings. Retrieved from 

Klein C, Hill MN, Chang SC, Hillard CJ, Gorzalka BB. Circulating endocannabinoid concentrations and sexual arousal in women. J Sex Med. 2012;9(6):1588-1601. doi:10.1111/j.1743-6109.2012.02708.x 

Leafly Staff. June 9, 2015 What is limonene and what does this cannabis terpene do. Leafly 

Lucas, P. Addiction Research & Theory 21.5 (2013): 435-442 

Malhi GS, Mann JJ. Depression. Lancet. 2018 Nov 24;392(10161):2299-2312.Mann SK, Marwaha R. Posttraumatic Stress Disorder. 2021 Sep 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–. PMID: 32644555. 

Manzanares J, Julian M, Carrascosa A. Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes. Curr Neuropharmacol. 2006;4(3):239-257. doi:10.2174/157015906778019527 

Marijuana And Anxiety: The States That Qualify May, 2021. Elevate. Retrieved from 

Moreira FA, Guimarães FS (2005) Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice. Eur J Pharmacol 512:199–205 

Murray, Krystina. August 11, 2021 The War on Drug’s Ongoing Impact on Black People. Addiction Center. Retrieved from 

Nagarkatti, P., Pandey, R., Rieder, S. A., Hegde, V. L., & Nagarkatti, M. (2009). Cannabinoids as novel anti-inflammatory drugs. Future medicinal chemistry, 1(7), 1333–1349. 

National Academies of Sciences, Engineering, and Medicine 2017. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press. 

NIDA. Understanding Drug Use and Addiction. National Institute on Drug Abuse website. June 6, 2018. Accessed February 20, 2019. 

Pandey R, Mousawy K, Nagarkatti M, Nagarkatti P (August 2009). "Endocannabinoids and immune regulation". Pharmacological Research. 60 (2): 85–92. 

Patel KR, Cherian J, Gohil K, Atkinson D. Schizophrenia: overview and treatment options. P T. 2014;39(9):638-645 

Pertwee RG. Cannabinoids and multiple sclerosis. Pharmacol Ther. 2002;95:165–174 

Richards JR et al. Unintentional Cannabis Ingestion in Children: A Systematic Review. J Pediatr. 2017 Nov;190:142-152. 

Rothwell, Jonathan. September 30, 2014 How the War on Drugs Damages Black Social Mobility. Brookings. Retrieved from 

Ruehle S, Rey AA, Remmers F, Lutz B. The endocannabinoid system in anxiety, fear memory and habituation. J Psychopharmacol. 2012;26(1):23-39. doi:10.1177/0269881111408958 

Mann SK, Marwaha R. Posttraumatic Stress Disorder. 2021 Sep 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–. PMID: 32644555. 

Sagar KA, Dahlgren MK, Racine MT, Dreman MW, Olson DP, Gruber SA (2016) Joint Effects: A Pilot Investigation of the Impact of Bipolar Disorder and Marijuana Use on Cognitive Function and Mood. PLoS ONE 11(6): e0157060. 

Sharkey KA, Darmani NA, Parker LA. Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system. Eur J Pharmacol. 2014;722:134-146. doi:10.1016/j.ejphar.2013.09.068 

Simple Guide to the Endocannabinoid System. Healthline Retrieved from 

State Medical Marijuana Laws. National Conference of State Legislatures. June 27, 2018. 

Stoner, Susan. PHD Effects of Marijuana on Mental Health: Anxiety Disorders University of Washington, 2017 

Substance Abuse and Mental Health Services Administration. (2020). Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, NSDUH Series H-55). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from  

Theisen, Eloise and Barrell, Amanda. March 21, 2021 What to know about cannabis and bipolar disorder 

Wang H, Xie H, Dey SK. Endocannabinoid signaling directs periimplantation events. AAPS J. 2006;8(2):E425-E432. doi:10.1007/BF02854916 

Wedman-St.Louis, Betty (2018). Cannabis : A Clinician’s Guide. CRC Press. What is marijuana?  

What is marijuana? National Institute on Drug Abuse. Retrieved from  

What is Psychosis? National Institute of Mental Health. 

White CM. The Pharmacologic and Clinical Effects of Illicit Synthetic Cannabinoids. J Clin Pharmacol. 2017 Mar;57(3):297-304. doi: 10.1002/jcph.827. Epub 2016 Oct 13. PMID: 27610597. 

Wong KU, Baum CR. Acute Cannabis Toxicity. Pediatr Emerg Care. 2019 Nov;35(1) 

Course Completion & CE Information

Category I Maryland BSWE Requirement

The Office of Continuing Professional Education at the University Of Maryland School Of Social Work is authorized by the Board of Social Work Examiners in Maryland to sponsor social work continuing education programs. This workshop qualifies for {6} Category I Continuing Education Units. The Office of Continuing Professional Education is also authorized by the Maryland Board of Psychologists and the Maryland Board of Professional Counselors to sponsor Category A continuing professional education.

Please refer to the tab "Live Interactive Webinar Policies & FAQs" for UMSSW Office of CPE policies regarding all live interactive webinar related matters.

Target Audience

Social Workers, LCPCs, and Psychologists

We welcome anyone interested in the topic!


Late Fees and Refunds

Fee & Registration:

Cost is $130 and includes CE credit. Registering after 9/28/23 will incur an additional $20 late fee. Cancellations* must be received 24 hours in advance prior to the workshop to receive a refund or an account credit.

*ALL cancellations will be subjected to a $35.00 administration fee.

Live Interactive Webinar Platforms


The Office of Continuing Professional Education hosts Live Interactive Webinars through two platforms: Zoom and WebEx.

Both platforms offer high quality and user-friendly webinar platforms for our registrants.


System Requirements:

  • Operating Systems: Windows XP or higher; MacOS 9 or higher; Android 4.0 or higher.
  • Internet Browser: Google Chrome; Firefox 10.0 or higher.

Our system is not compatible with the Safari web browser.

  • Broadband Internet Connection: Cable, High-speed DSL and any other medium that is internet accessible.

**Please have your device charging at all times to ensure that your device does not lose power during the webinar.


Course Interaction Requirements:

To participate in Live Interactive Webinars, you MUST have a device that allows you to view the presentation on screen and hear the instructor at all times. We do not allow participants to call-in from their phones or mobile devices and solely listen to the presentation. Participation in Live Interactive Webinars is mandatory.

Webinar Policies & FAQs

Click The Link to View The Webinar Policies & FAQs